Clinical and molecular pathogenesis of varicella virus infection

Viral Immunology

Volumn 16, Issue 3, 2003, Pages 243-258

  Gilden, Donald H ^a,b   Cohrs, Randall J ^a   Mahalingam, Ravi ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTONOMIC NERVOUS SYSTEM; CELLULAR IMMUNITY; CHICKENPOX; CHRONIC DISEASE; CRANIAL NERVE; DORSAL ROOT; GANGLION; HERPES SIMPLEX VIRUS; HERPES ZOSTER; HOST CELL; IMMUNE DEFICIENCY; INCIDENCE; INOCULATION; NERVE FIBER; NONHUMAN; PAIN; PATHOGENESIS; PERSISTENT INFECTION; POSTHERPETIC NEURALGIA; RASH; REVIEW; SIMIAN VIRUS; VARICELLA ZOSTER VIRUS; VASCULAR DISEASE; VIRUS LATENCY; VIRUS REACTIVATION;

CERCOPITHECINE HERPESVIRUS 9; DNA VIRUSES; HERPESVIRIDAE; HUMAN HERPESVIRUS 3; PRIMATES; SIMIAE; SIMPLEXVIRUS;

EID: 0141994765     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/088282403322396073     Document Type: Review

References (162)

1. Annunziato, P., P. LaRussa, P. Lee, et al. 1998. Evidence of latent varicella-zoster virus in rat dorsal root ganglia. J. Infect. Dis. 178:S48-S51.
2. Arbeit, R.D., J.A. Zaia, M.A. Valerio, et al. 1982. Infection of human peripheral blood mononuclear cells by varicella-zoster virus. Intervirology 18:56-65.
3. Arvin, A.M., C.M. Koropchak, and A.E. Wittek. 1983. Immunologic evidence of reinfection with varicella-zoster virus. J. Infect. Dis. 148:200-205.
4. Arvin, A.M., C.M. Koropchak, B.R.G. Williams, et al. 1986. Early immune response in healthy and immunocompromised subjects with primary varicella-zoster virus infection. J. Infect. Dis. 154:422-429.
5. Baxi, M.K., S. Efstathiou, G. Lawrence, et al. 1995. The detection of latency-associated transcripts of equine herpesvirus 1 in ganglionic neurons. J. Gen. Virol. 76:3113-3118.
6. Ben-Porat, T., and F.J. Rixon. 1979. Replication of herpesvirus DNA. IV: analysis of concatemers. Virology 94:61-70.
7. Berger, R., G. Florent, and M. Just. 1981. Decrease of the lymphoproliferative response to varicella-zoster virus antigen in the aged. Infect. Immun. 32:24-27.
8. Betz, J.L., and S.G. Wydoski. 1993. Functional interaction of varicella zoster virus gene 62 protein with the DNA sequence bound by herpes simplex virus ICP4 protein. Virology 195:793-797.
9. Bodensteiner, J.B., M.R. Hille, and J.E. Riggs. 1992. Clinical features of vascular thrombosis following varicella. Am. J. Dis. Child. 146:100-102.
10. Borchers, K., U. Wolfinger, B. Lawrenz, et al. 1997. Equine herpesvirus 4 DNA in trigeminal ganglia of naturally infected horses detected by direct in situ PCR. J. Gen. Virol. 78:1109-1114.
11. Boucaud, D., H. Yoshitake, J. Hay, et al. 1998. The varicella-zoster virus (VZV) open-reading frame 29 protein acts as a modulator of a late VZV gene promoter. J. Infect. Dis. 178:S34-S38.
12. Bourdette, D.N., N.L. Rosenberg, and F.M. Yhatsu. 1983. Herpes zoster ophthalmicus and delayed ipsilateral cerebral infarction. Neurology 33:1428-1432.
13. Bratanich, A.C., N.D. Hanson, and C.J. Jones. 1992. The latency-related gene of bovine herpesvirus 1 inhibits the activity of immediate-early transcription unit 1. Virology 191:988-991.
14. Brown, G.R. 1976. Herpes zoster: correlation of age, sex, distribution, neuralgia and associated disorders. South. Med. J. 69:576-578.
15. Cabirac, G.F., R. Mahalingam, M. Wellish, et al. 1990. Trans-activation of viral tk promoters by proteins encoded by varicella zoster virus open reading frames 61 and 62. Virus Res. 15:57-68.
16. Caekebeke, J.F.V., A.C.B. Peters, B. Vandvik, et al. 1990. Cerebral vasculopathy associated with primary varicella infection. Arch. Neurol. 47:1033-1035.
17. Chen, Y.M., and D.M. Knipe. 1996. A dominant mutant form of the herpes simplex virus ICP8 protein decreases viral late gene transcription. Virology 221:281-290.
18. Cheung, A.K. 1989. Detection of pseudorabies virus transcripts in trigeminal ganglia of latently infected swine. J. Virol. 63:2908-2913.
19. Cheung, A.K. 1991. Cloning of the latency gene and the early protein 0 gene of pseudorabies virus. J. Virol. 65:5260-5271.
20. Clarke, P., S.D. Rabkin, M.V. Inman, et al. (1992) Molecular analysis of simian varicella virus DNA. Virology 190:597-605.
21. Clarke, P., T. Beer, R. Cohrs, et al. 1995. Configuration of latent varicella-zoster virus DNA. J. Virol. 69:8151-8154.
22. Clarkson, M.J., E. Thorpe, and K. McCarthy. 1967. A virus disease of captive vervet monkeys (Cercopithecus aethiops) caused by a new herpesvirus. Arch. Gesamte Virusforsch. 22:219-234.
23. Cohen, J.I., and S.E. Straus. 2000. Varicella-zoster virus and its replication, pp. 2707-2730. In: D.M. Knipe and P.M. Howley (eds.), Fields Virology. Lippincott, Williams & Wilkins, Philadelphia.
24. Cohen, J.I., T. Moskal, M. Shapiro, et al. 1996. Varicella in chimpanzees. J. Med. Virol. 50:289-292.
25. Cohrs, R.J., M. Barbour, and D.H. Gilden. 1996. Varicella-zoster virus (VZV) transcription during latency in human ganglia: detection of transcripts mapping to genes 21, 29, 62, and 63 in a cDNA library enriched for VZV RNA. J. Virol. 70:2789-2796.
26. Cohrs, R.J., J. Randall, J. Smith, et al. 2000. Analysis of individual human trigeminal ganglia for latent herpes simplex virus type 1 and varicella-zoster virus nucleic acids using real-time PCR. J. Virol. 74:11464-11471.
27. Cohrs, R., J. Wischer, C. Essman, et al. 2002. Characterization of varicella-zoster virus gene 21 and 29 proteins in infected cells. J. Virol. 76:7228-7238.
28. Cohrs, R.J., D.H. Gilden, P.R. Kinchington, et al. 2003. Varicella-zoster virus gene 66 transcription and translation in latently infected human ganglia. J. Virol. 77:6660-6665.
29. Croen, K.D., J.M. Ostrove, L.J. Dragovic, et al. 1988. Patterns of gene expression and sites of latency in human nerve ganglia are different for varicella-zoster and herpes simplex viruses. Proc. Natl. Acad. Sci. USA 85:9773-9777.
30. Croen, K.D., J.M. Ostrove, L. Dragovic, et al. 1991. Characterization of herpes simplex virus type 2 latency-associated transcription in human sacral ganglia and in cell culture. J. Infect. Dis. 163:23-28.
31. Davison, A.J. 1991. Varicella-zoster virus. The Fourteenth Fleming Lecture. J. Gen. Virol. 72:475-486.
32. Davison, A.J., and J.E. Scott. 1986. The complete DNA sequence of varicella-zoster virus. J. Gen. Virol. 67:1759-1816.
33. de Jong, M.D., J.F. Weel, T. Schuurman, et al. 2000. Quantitation of varicella-zoster virus DNA in whole blood, plasma, and serum by PCR and electrochemiluminescence. J. Clin. Microbiol. 38:2568-2573.
34. Debrus, S., C. Sadzot-Delvaux, A.F. Nikkels, et al. 1995. Varicella-zoster virus gene 63 encodes an immediate-early protein that is abundantly expressed during latency. J. Virol. 69:3240-3245.
35. Defechereux, P., L. Melen, L. Baudoux, et al. 1993. Characterization of the regulatory functions of varicella-zoster virus open reading frame 4 gene product. J. Virol. 67:4379-4385.
36. Devlin, M.E., D.H. Gilden, R. Mahalingam, et al. 1992. Peripheral blood mononuclear cells of the elderly contain varicella-zoster virus DNA. J. Infect. Dis. 165:619-622.
37. Disney, G.H., and R.D. Everett. 1990. A herpes simplex virus type 1 recombinant with both copies of the Vmw175 coding sequences replaced by the homologous varicella-zoster virus open reading frame. J. Gen. Virol. 71:2681-2689.
38. Disney, G.H., T.A. McKee, C.M. Preston, et al. 1990. The product of varicella-zoster virus gene 62 autoregulates its own promoter. J. Gen. Virol. 71:2999-3003.
39. Doyle, P.W., G. Gibson, and C.L. Dolman. 1983. Herpes zoster ophthalmicus with contralateral hemiplegia: identification of cause. Ann. Neurol. 14:84-85.
40. Dueland, A.N., J.R. Martin, M.E. Devlin, et al. 1992. Acute simian varicella infection. Clinical, laboratory, pathologic, and virologic features. Lab. Invest. 66:762-773.
41. Dueland, A.N., T. Ranneberg-Nilsen, and M. Degre. 1995. Detection of latent varicella zoster virus DNA and human gene sequences in human trigeminal ganglia by in situ amplification combined with in situ hybridization. Arch. Virol. 140:2055-2066.
42. Dumas, A.M., J.L.M.C. Geelen, W. Maris, et al. 1980. Infectivity and molecular weight of varicella-zoster virus DNA. J. Gen. Virol. 47:233-235.
43. Efstathiou, S., A.C. Minson, H.J. Field, et al. 1986. Detection of herpes simplex virus-specific DNA sequences in latently infected mice and in humans. J. Virol. 57:446-455.
44. Eidelberg, D., A. Sotrel, D.S. Horoupian, et al. 1986. Thrombotic cerebral vasculopathy associated with herpes zoster. Ann. Neurol. 19:7-14.
45. Feldman, L.T., A.R. Ellison, C.C. Voytek, et al. 2002. Spontaneous molecular reactivation of herpes simplex virus type 1 latency in mice. Proc. Natl. Acad. Sci. USA 99:978-983.
46. Felsenfeld, A.D., and N.J. Schmidt. 1979. Varicella-zoster virus immunizes patas monkeys against simian varicella-like disease. J. Gen. Virol. 42:171-178.
47. Fletcher, T.M., and W.L. Gray. 1992. Simian varicella virus: characterization of virion and infected cell polypeptides and the antigenic cross-reactivity with varicella-zoster virus. J. Gen. Virol. 73:1209-1215.
48. Fukumoto, S., M. Kinjo, K. Hokamura, et al. 1986. Subarachnoid hemorrhage and granulomatous angiitis of the basilar artery: demonstration of the varicella-zoster-virus in the basilar artery lesions. Stroke 17:1024-1028.
49. Gilden, D.H., and R.I. Katz. 2003. Surgical induction of contralateral homologous dermatomal distribution zoster. Arch. Neurol. 60:616-617.
50. Gilden, D.H., A. Vafai, Y. Shtram, et al. 1983. Varicella-zoster virus DNA in human sensory ganglia. Nature 306:478-480.
51. Gilden, D.H., Y. Rozenman, R. Murray, et al. 1987. Detection of varicella-zoster virus nucleic acid in neurons of normal human thoracic ganglia. Ann. Neurol. 22:377-380.
52. Gilden, D.H., M. Devlin, M. Wellish, et al. 1988. Persistence of varicella-zoster virus DNA in blood MNCs of patients with varicella or zoster. Virus Genes 2:299-305.
53. Gilden, D.H., R.R. Wright, S.A. Schneck, et al. 1994. Zoster sine herpete, a clinical variant. Ann. Neurol. 35:530-533.
54. Gilden, D.H., B.K. Kleinschmidt-DeMasters, M. Wellish, et al. 1996. Varicella zoster virus, a cause of waxing and waning vasculitis. NEJM case 5-1995 revisited. Neurology 47:1441-1446.
55. Gilden, D.H., J.L. Bennett, B.K. Kleinschmidt-DeMasters, et al. 1998. The value of cerebrospinal fluid antiviral antibody in the diagnosis of neurologic disease produced by varicella zoster virus. J. Neurol. Sci. 159;140-144.
56. Gilden, D.H., R. Gesser, J. Smith, et al. 2001. Presence of VZV and HSV-1 DNA in human nodose and celiac ganglia. Virus Genes 23:145-147.
57. Gilden, D.H., R.J. Cohrs, A.R. Hayward, et al. 2003. Chronic varicella zoster virus ganglionitis - a possible cause of postherpetic neuralgia. J. Neurovirol. 9:404-407.
58. Gray, W.L., and J.E. Oakes. 1984. Simian varicella virus DNA shares homology with human varicella-zoster virus DNA. Virology 136:241-246.
59. Gray, W.L., C.Y. Pumphrey, W.T. Ruyechan, et al. 1992. The simian varicella virus and varicella zoster virus genomes are similar in size and structure. Virology 186:562-572.
60. Gray, W.L., B. Starnes, M.W. White, et al. 2001. The DNA sequence of the simian varicella virus genome. Virology 284:123-130.
61. Hardy, I., A.A. Gershon, S.P. Steinberg, et al. 1991. The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. N. Engl. J. Med. 325:1545-1550.
62. Hayakawa, Y., and R.W. Hyman. 1987. Isomerization of the UL region of varicella-zoster virus DNA. Virus Res. 8:25-31.
63. Hayward, A., M. Levin, W. Wolf, et al. 1991. Varicella-zoster virus-specific immunity after herpes zoster. J. Infect. Dis. 163:873-875.
64. Herrmann, C.H., M.O. Gold, and A.P. Rice. 1996. Viral transactivators specifically target distinct cellular protein kinases that phosphorylate the RNA polymerase II C-terminal domain, Nucleic Acids Res, 24:501-508.
65. Honess, R.W., and B. Roizman. 1974. Regulation of herpesvirus macromolecular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins. J. Virol. 14:8-19.
66. Hope-Simpson, R.E. 1965. The nature of herpes zoster: a long-term study and a new hypothesis. Proc. R. Soc. Med. 58:9-20.
67. Hossain, A., L.M. Schang, and C. Jones. 1995. Identification of gene products encoded by the latency-related gene of bovine herpesvirus 1. J. Virol. 69:5345-5352.
68. Hyman, R.W., J.R. Ecker, and R.B. Tenser. 1983, Varicella-zoster virus RNA in human trigeminal ganglia. Lancet 2:814-816.
69. Iltis, J.P., M.C. Arrons, G.A. Castellano, et al. 1982. Simian varicella virus (delta herpesvirus) infection of patas monkeys leading to pneumonia and encephalitis. Proc. Soc. Exp. Biol. Med. 169:266-279.
70. Inchauspe, G., and J.M. Ostrove. 1989. Differential regulation by varicella-zoster virus (VZV) and herpes simplex virus type-1 trans-activating genes. Virology 173:710-714.
71. Inchauspe, G., S. Nagpal, and J. M. Ostrove. 1989. Mapping of two varicella-zoster virus-encoded genes that activate the expression of viral early and late genes. Virology 173:700-709.
72. Jackers, P., P. Defechereux, L. Baudoux, et al. 1992. Characterization of regulatory functions of the varicella-zoster virus gene 63-encoded protein. J. Virol. 66:3899-3903.
73. Jacob, R.J., L.S. Morse, and B. Roizman. 1979. Anatomy of herpes simplex virus DNA. XII. Accumulation of head-to-tail concatemers in nuclei of infected cells and their role in the generation of the four isomeric arrangements of viral DNA. J. Virol. 29:448-457.
74. Kamholz, J., and G. Tremblay. 1985. Chickenpox with delayed contralateral hemiparesis caused by cerebral angiitis. Ann. Neurol. 18:358-360.
75. Kennedy, P.G., E. Grinfeld, and J.W. Gow. 1998. Latent varicella-zoster virus is located predominantly in neurons in human trigeminal ganglia. Proc. Natl. Acad. Sci. USA 95:4658-4662.
76. Kennedy, P.G., E. Grinfeld, and J.W. Gow. 1999. Latent varicella-zoster virus in human dorsal root ganglia. Virology 258:451-454.
77. Kennedy, P.G., E. Grinfeld, and J.E. Bell. 2000. Varicella-zoster virus gene expression in latently infected and explanted human ganglia. J. Virol. 74:11893-11898.
78. Kennedy, P.G., E. Grinfeld, S. Bontems, et al. 2001. Varicella-zoster virus gene expression in latently infected rat dorsal root ganglia. Virology 289:218-223.
79. Kinchington, P.R., and J.I. Cohen. 2000. Viral proteins, pp. 74-104. In: A.M. Arvin and A.A. Gershon (eds.), Varicella-Zoster Virus. Cambridge University Press, Cambridge.
80. Kinchington, P.R., W.C. Reinhold, T.A. Casey, et al. 1985. Inversion and circularization of the varicella-zoster virus genome. J. Virol. 56:194-200.
81. Kinchington, P.R., K. Fite, and S.E. Turse. 2000. Nuclear accumulation of IE62, the varicella-zoster virus (VZV) major transcriptional regulatory protein, is inhibited by phosphorylation mediated by the VZV open reading frame 66 protein kinase. J. Virol. 74:2265-2277.
82. Koropchak, C.M., S.M. Solem, P.S. Diaz, et al. 1989. Investigation of varicella-zoster virus infection of lymphocytes by in situ hybridization. J. Virol. 63:2392-2395.
83. Kost, R.G., H. Kupinsky, and S.E. Straus. 1995. Varicella-zoster virus gene 63: transcript mapping and regulatory activity. Virology 209:218-224.
84. Kutish, G., T. Mainprize, and D. Rock. 1990. Characterization of the latency-related transcriptionally active region of the bovine herpesvirus 1 genome. J. Virol. 64:5730-5737.
85. LaGuardia, J.J., and D.H. Gilden. 2001. Varicella-zoster virus: a re-emerging infection. J. Invest. Dermatol. Symp. Proc. 6:183-187.
86. LaGuardia, J.J., R.J. Cohrs, and D.H. Gilden. 1999. Prevalence of varicella-zoster virus DNA in dissociated human trigeminal ganglion neurons and nonneuronal cells. J. Virol. 73:8571-8577.
87. Leopold, N.A. 1993. Chickenpox stroke in an adult. Neurology 43:1852-1853.
88. Levin, M.J., M. Murray, H.A. Rotbart, et al. 1994. The immune response of elderly individuals to a live attenuated varicella vaccine. J. Infect. Dis. 166:253-259.
89. Liu, G.T., and G.L. Holmes. 1990. Varicella with delayed contralateral hemiparesis detected by MRI. Pediatr. Neurol. 6:131-134.
90. Lowry, P.W., C. Sabella, C.M. Koropchak, et al. 1993. Investigation of the pathogenesis of varicella-zoster virus infection in guinea pigs by using polymerase chain reaction. J. Infect. Dis. 167:78-83.
91. Lungu, O., P.W. Annunziato, A. Gershon, et al. 1995. Reactivated and latent varicella-zoster virus in human dorsal root ganglia. Proc. Natl. Acad. Sci. USA 92:10980-10984.
92. Lungu, O., C.A. Panagiotidis, P.W. Annunziato, et al. 1998. Aberrant intracellular localization of varicella-zoster virus regulatory proteins during latency. Proc. Natl. Acad. Sci. USA 95:7080-7085.
93. Maguire, H.F., and R.W. Hyman. 1986. Polyadenylated, cytoplasmic transcripts of varicella-zoster virus. Intervirology 26:181-191.
94. Mahalingam, R., M. Wellish, W. Wolf, et al. 1990. Latent varicella zoster virus DNA in human trigeminal and thoracic ganglia. N. Engl. J. Med. 323:627-631.
95. Mahalingam, R., M. Wellish, J. Brucklier, et al. 1995. Persistence of varicella-zoster virus DNA in elderly patients with postherpetic neuralgia. J. Neurovirol. 1:130-133.
96. Mahalingam, R., M. Wellish, R. Cohrs, et al. 1996. Expression of protein encoded by varicella-zoster virus open reading frame 63 in latently infected human ganglionic neurons. Proc. Natl. Acad. Sci. USA 93:2122-2124.
97. Mahalingam, R., T. White, M. Wellish, et al. 2000. Sequence analysis of the leftward end of simian varicella virus (EcoRI-I fragment) reveals the presence of an 8-bp repeat flanking the unique long segment and an 881-bp open-reading frame that is absent in the varicella zoster virus genome. Virology 274:420-428.
98. Mahalingam, R., M. Wellish, K. Soike, et al. 2001. Simian varicella virus infects ganglia before rash in experimentally infected monkeys. Virology 279:339-342.
99. Mahalingam, R., V. Traina-Dorge, M. Wellish, et al. 2002. Naturally acquired simian varicella virus infection in African green monkeys. J. Virol. 76:8548-8550.
100. Mainka, C., B. Fuss, H. Geiger, et al. 1998. Characterization of viremia at different stages of varicella-zoster virus infection. J. Med. Virol. 56:91-98.
101. Matsunaga, Y., K. Yamanishi, and M. Takahashi. 1982. Experimental infection and immune response of guinea pigs with varicella-zoster virus. Infect. Immun. 37:407-412.
102. McGeoch, D.J., A. Dolan, S. Donald, et al. 1985. Sequence determination and genetic content of the short unique region in the genome of herpes simplex virus type 1. J. Mol. Biol. 181:1-13.
103. McGeoch, D.J., A. Dolan, S. Donald, et al. 1986. Complete DNA sequence of the short repeat region in the genome of herpes simplex virus type 1. Nucleic Acids Res. 14:1727-1745.
104. McGeoch, D.J., M.A. Dalrymple, A.J. Davison, et al. 1988. The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1. J. Gen. Virol. 69:1531-1574.
105. Meier, J.L., R.P. Holman, K.D. Croen, et al. 1993. Varicella-zoster virus transcription in human trigeminal ganglia. Virology 193:193-200.
106. Melanson, M., C. Chalk, L. Georgevich, et al. 1996. Varicella-zoster virus DNA in CSF and arteries in delayed contralateral hemiplegia: evidence for viral invasion of cerebral arteries. Neurology 47:569-570.
107. Miller, A.E. 1980. Selective decline in cellular immune response to varicella-zoster in the elderly. Neurology 30:582-587.
108. Mitchell, W.J., S.L. Deshmane, A. Dolan, et al. 1990. Characterization of herpes simplex virus type 2 transcription during latent infection of mouse trigeminal ganglia. J. Virol. 64:5342-5348.
109. Mitchell, W.J., R.P. Lirette, and N.W. Fraser. 1990. Mapping of low abundance latency-associated RNA in the trigeminal ganglia of mice latently infected with herpes simplex virus type 1. J. Gen. Virol. 71:125-132.
110. + T lymphocytes and epidermal cells in SCID-hu mice. J. Virol. 69:5236-5242.
111. Moriuchi, H., M. Moriuchi, S.E. Straus, et al. 1993. Varicella-zoster virus (VZV) open reading frame 61 protein transactivates VZV gene promoters and enhances the infectivity of VZV DNA. J. Virol. 67:4290-4295.
112. Moriuchi, H., M. Moriuchi, and J.I. Cohen. 1994. The RING finger domain of the varicella-zoster virus open reading frame 61 protein is required for its transregulatory functions. Virology 205:238-246.
113. Moriuchi, M., H. Moriuchi, S.E. Straus, et al. 1994. Varicella-zoster virus (VZV) virion-associated transactivator open reading frame 62 protein enhances the infectivity of VZV DNA. Virology 200:297-300.
114. Myers, M.G., and B.L. Connelly. 1992. Animal models of varicella. J. Infect. Dis. 166:548-550.
115. Myers, M.G., H.L. Duer, and C.K. Hausler. 1980. Experimental infection of guinea pigs with varicella-zoster virus. J. Infect. Dis. 142:414-420.
116. Myers, M.G., L.R. Stanberry, and B.J. Edmond. 1985. Varicella-zoster virus infection of strain 2 guinea pigs. J. Infect. Dis. 151:106-113.
117. Nagpal, S., and J.M. Ostrove. 1991. Characterization of a potent varicella-zoster virus-encoded trans-repressor. J. Virol. 65:5289-5296.
118. Nau, R., M. Lantsch, M. Stiefel, et al. 1998. Varicella zoster virus-associated focal vasculitis without herpes zoster: recovery after treatment with acyclovir. Neurology 51:914-915.
119. Ostrove, J.M., W. Reinhold, C.M. Fan, et al. 1985. Transcription mapping of the varicella-zoster virus genome. J. Virol. 56:600-606.
120. Padovan, D. and C.A. Cantrell. 1986. Varicella-like herpesvirus infections of nonhuman primates. Lab. Anim. Sci. 36:7-13.
121. Perera, L.P., J.D. Mosca, M. Sadeghi-Zadeh, et al. 1992. The varicella-zoster virus immediate early protein, IE62, can positively regulate its cognate promoter. Virology 191:346-354.
122. Perry, L.J., and D.J. McGeoch. 1988. The DNA sequences of the long repeat region and adjoining parts of the long unique region in the genome of herpes simplex virus type 1. J. Gen. Virol. 69:2831-2846.
123. Priola, S.A., and J.G. Stevens. 1991. The 5′ and 3′ limits of transcription in the pseudorabies virus latency associated transcription unit. Virology 182:852-856.
124. Priola, S.A., D.P. Gustafson, E.K. Wagner, et al. 1990. A major portion of the latent pseudorabies virus genome is transcribed in trigeminal ganglia of pigs. J. Virol. 64:4755-4760.
125. Pumphrey, C.Y., and W.L. Gray. 1992. The genomes of simian varicella virus and varicella zoster virus are co-linear. Virus Res. 26:255-266.
126. Reinhold, W.C., S.E. Straus, and J.M. Ostrove. 1988. Directionality and further mapping of varicella zoster virus transcripts. Virus Res. 9:249-261.
127. Rice, S.A., M.C. Long, V. Lam, et al. 1995. Herpes simplex virus immediate-early protein ICP22 is required for viral modification of host RNA polymerase II and establishment of the normal viral transcription program. J. Virol. 69:5550-5559.
128. Roberts, E.D., G.B. Baskin, K. Soike, et al. 1984. Pathologic changes of experimental simian varicella (Delta herpesvirus) infection in African green monkeys (Cercopithecus aethiops). Am. J. Vet. Res. 45:523-530.
129. Rock, D.L., and N.W. Fraser. 1983. Detection of HSV-1 genome in central nervous system of latently infected mice. Nature 302:523-525.
130. Rock, D.L., and N.W. Fraser. 1985. Latent herpes simplex virus type 1 DNA contains two copies of the virion DNA joint region. J. Virol. 55:849-852.
131. Rosenblum, W.I., and M.G. Hadfield. 1972. Granulomatous angiitis of the nervous system in cases of herpes zoster and lymphosarcoma. Neurology 22:348-354.
132. Ruppenthal, M. 1980. Changes of the central nervous system in herpes zoster. Acta Neuropathol. 52:59-68.
133. Sadzot-Delvaux, C., M.P. Merville-Louis, P. Delree, et al. 1990. An in vivo model of varicella-zoster virus latent infection of dorsal root ganglia. J. Neurosci. Res. 26:83-89.
134. Schang, L.M., A. Hossain, and C. Jones. 1996. The latency-related gene of bovine herpesvirus 1 encodes a product which inhibits cell cycle progression. J. Virol. 70:3807-3814.
135. Sharp, M., K. Terada, A. Wilson, et al. 1992. The kinetics and protein specificity of T-lymphocyte cytotoxicity in healthy adults immunized with live attenuated varicella vaccine. J. Infect. Dis. 165:852-858.
136. Shiraki, K., and R.W. Hyman. 1987. The immediate early proteins of varicella-zoster virus. Virology 156:423-426.
137. Soike, K.F., S.R. Rangan, and P.J. Gerone. 1984. Viral disease models in primates. Adv. Vet. Sci. Comp. Med. 28:151-199.
138. Soike, K.F., P.M. Keller, and R.W. Ellis. 1987. Immunization of monkeys with varicella-zoster virus glycoprotein antigens and their response to challenge with simian varicella virus. J. Med. Virol. 22:307-313.
139. Soong, W., J.C. Schultz, A.C. Patera, et al. 2000. Infection of human T lymphocytes with varicella-zoster virus: an analysis with viral mutants and clinical isolates. J. Virol. 74:1864-1870.
140. Spencer, C.A., M.E. Dahmus, and S.A. Rice. 1997. Repression of host RNA polymerase II transcription by herpes simplex virus type 1. J. Virol. 71:2031-2040.
141. Stevens, J.G., E.K. Wagner, G.B. Devi-Rao, et al. 1987. RNA complementary to a herpesvirus alpha gene mRNA is prominent in latently infected neurons. Science 235:1056-1059.
142. Straus, S.E., J. Owens, W.T. Ruyechan, et al. 1982. Molecular cloning and physical mapping of varicella-zoster virus DNA. Proc. Natl. Acad. Sci. USA 79:993-997.
143. Takahashi, M., Y. Okuno, T. Otsuka, et al. 1975. Development of a live attenuated varicella vaccine. Biken. J. 18:25-33.
144. Tenser, R.B., and R.W. Hyman. 1987. Latent herpesvirus infections of neurons in guinea pigs and humans. Yale J. Biol. Med. 60:159-167.
145. Terada, K., T. Niizuma, S. Kawano, et al. 1998. Detection of varicella-zoster virus DNA in peripheral mononuclear cells from patients with Ramsay Hunt syndrome or zoster sine herpete. J. Med. Virol. 56:359-363.
146. Thomas, S.L., J.G. Wheeler, and A.J. Hall. 2002. Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study. Lancet 360:678-682.
147. Thompson, R.L., and N.M. Sawtell. 2000. Replication of herpes simplex virus type 1 within trigeminal ganglia is required for high frequency but not high viral genome copy number latency. J. Virol. 74:965-974.
148. Tyler, J.K., and R.D. Everett. 1994. The DNA binding domains of the varicella-zoster virus gene 62 and herpes simplex virus type 1 ICP4 transactivator proteins heterodimerize and bind to DNA. Nucleic Acids Res. 22:711-721.
149. Vafai, A., M. Wellish, and D.H. Gilden. 1988. Expression of varicella-zoster virus in blood mononuclear cells of patients with postherpetic neuralgia. Proc. Natl. Acad. Sci. USA 85:2767-2770.
150. Wagner, E.K. 1994. The herpes simplex type 1 virus latency gene, pp. 210-221. In: Y. Becker and G. Darai (eds.), Frontiers of Virology. Springer-Verlag, Heidelberg.
151. Walz-Cicconi, M.A., R.M. Rose, G.J. Dammin, et al. 1986. Inoculation of guinea pigs with varicella-zoster virus via the respiratory route. Arch. Virol. 88:265-277.
152. Wenner, H.A., D. Abel, S. Barrick, et al. 1977. Clinical and pathogenetic studies of Medical Lake macaque virus infections in cynomolgus monkeys (simian varicella). J. Infect. Dis. 135:611-622.
153. White, T.M., R. Mahalingam, G. Kolhatkar, et al. 1997. Identification of simian varicella virus homologues of varicella zoster virus genes. Virus Genes 15:265-269.
154. White, T.M., D.H. Gilden, and R. Mahalingam. 2001. An animal model of varicella virus infection. Brain Pathol. 11:475-479.
155. + blood mononuclear cells for years after intratracheal inoculation of African green monkeys. Virology 303:192-198.
156. White, T.M., R. Mahalingam, V. Traina-Dorge, et al. 2002. Simian varicella virus DNA is present and transcribed months after experimental infection of adult African green monkeys. J. Neurovirol. 8:191-203.
157. Wolf, R.H., H.F. Smetana, W.P. Allen, et al. 1974. Pathology and clinical history of Delta herpesvirus infection in patas monkeys. Lab. Anim. Sci. 24:218-221.
158. Wroblewska, Z., M. Devlin, K. Reilly, et al. 1982. The production of varicella zoster virus antiserum in laboratory animals. Arch. Virol. 74:233-238.
159. Wu, C.L., and K.W. Wilcox. 1991. The conserved DNA-binding domains encoded by the herpes simplex virus type 1 ICP4, pseudorabies virus IE180, and varicella-zoster virus ORF62 genes recognize similar sites in the corresponding promoters. J. Virol. 65:1149-1159.
160. Zabolotny, J.M., C. Krummenacher, and N.W. Fraser. 1997. The herpes simplex virus type 1 2.0-kilobase latency-associated transcript is a stable intron which branches at a guanosine. J. Virol. 71:4199-4208.
161. Zerboni, L., M. Sommer, C.F. Ware, et al. 2000. Varicella-zoster virus infection of a human CD4-positive T-cell line. Virology 270:278-285.
162. Zwaagstra, J.C., H. Ghiasi, S.M. Slanina, et al. 1990. Activity of herpes simplex virus type 1 latency-associated transcript (LAT) promoter in neuron-derived cells: evidence for neuron specificity and for a large LAT transcript. J. Virol. 64:5019-5028.